Cargando…

Rhythm versus rate control for atrial fibrillation in heart failure with preserved ejection fraction

BACKGROUND: There are few prospective studies assessing the benefits of rhythm control of atrial fibrillation (AF) in patients with heart failure and preserved ejection fraction (HFpEF), which accounts for 50% of all heart failure patients. OBJECTIVE: Conduct a meta-analysis to assess the effects of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Sadawi, Mohammed, Aleem, Saadat, Aslam, Faisal, Jacobs, Robin, Stevens, Gregg, Almasry, Ibrahim, Singh, Abhijeet, Fan, Roger, Rashba, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626734/ https://www.ncbi.nlm.nih.gov/pubmed/36340484 http://dx.doi.org/10.1016/j.hroo.2022.06.009

Ejemplares similares

Effect of gender on atrial fibrillation ablation outcomes using a propensity score–matched analysis
por: Al-Sadawi, Mohammed, et al.
Publicado: (2023)

Effects of GLP-1 Agonists on mortality and arrhythmias in patients with Type II diabetes
por: Al-Sadawi, Mohammed A., et al.
Publicado: (2023)

Effects of rhythm control on left atrial structure remodeling in atrial fibrillation and heart failure with preserved ejection fraction
por: Bai, Lin, et al.
Publicado: (2023)

Association of late gadolinium enhancement in cardiac magnetic resonance with mortality, ventricular arrhythmias, and heart failure in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis
por: Al-Sadawi, Mohammed, et al.
Publicado: (2023)

Prognostic impact of left atrial function in heart failure with preserved ejection fraction in sinus rhythm vs. persistent atrial fibrillation
por: Schönbauer, Robert, et al.
Publicado: (2021)

Restoration of sinus rhythm by pulmonary vein isolation improves heart failure with preserved ejection fraction in atrial fibrillation patients
por: Rattka, Manuel, et al.
Publicado: (2020)

Left atrial minimal volume: association with diastolic dysfunction and heart failure in patients in sinus rhythm or atrial fibrillation with preserved ejection fraction
por: Ben-Arzi, Assaf, et al.
Publicado: (2021)

Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
por: Ţica, Otilia, et al.
Publicado: (2022)

Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines—Heart Failure
por: Kelly, Jacob P., et al.
Publicado: (2019)

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis
por: van den Berg, Maarten P, et al.
Publicado: (2019)

The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fraction
por: Weerts, Jerremy, et al.
Publicado: (2021)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction
por: Liu, Xiao, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions
por: Fauchier, Laurent, et al.
Publicado: (2023)

Insights on Distinct Left Atrial Remodeling Between Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction
por: Kuo, Jen-Yuan, et al.
Publicado: (2022)

Atrial Fibrillation and Outcomes in Heart Failure With Preserved Versus Reduced Left Ventricular Ejection Fraction
por: McManus, David D., et al.
Publicado: (2013)

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction
por: Son, Mi Kyoung, et al.
Publicado: (2020)

Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2021)

Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
por: Gierula, John, et al.
Publicado: (2022)

Atrial fibrillation ablation in patients with heart failure with preserved ejection fraction: Complexities in diagnosis and treatment
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2022)

Outcomes of patients with heart failure with preserved ejection fraction undergoing catheter ablation of atrial fibrillation
por: Krishnamurthy, Amrita, et al.
Publicado: (2022)

Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction
por: Johner, Nicolas, et al.
Publicado: (2022)

Cryoballoon ablation for atrial fibrillation in patients with heart failure with mildly reduced and preserved ejection fraction
por: Chen, Chaofeng, et al.
Publicado: (2022)

Loss of myeloid differentiation protein 1 promotes atrial fibrillation in heart failure with preserved ejection fraction
por: Shuai, Wei, et al.
Publicado: (2020)

Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta‐analysis
por: Gu, Gaoyang, et al.
Publicado: (2022)

Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction
por: Yang, Eunice, et al.
Publicado: (2022)

Long‐term events following catheter‐ablation for atrial fibrillation in heart failure with preserved ejection fraction
por: Ishiguchi, Hironori, et al.
Publicado: (2022)

Impact of catheter ablation for persistent atrial fibrillation with heart failure, compared to preserved and reduced ejection fraction
por: Inamura, Y, et al.
Publicado: (2023)

Relationships of Atrial Fibrillation at Diagnosis and Type of Atrial Fibrillation During Follow-up With Long-Term Outcomes for Heart Failure With Preserved Ejection Fraction
por: Nakatani, Daisaku, et al.
Publicado: (2022)

Medication unmasked Brugada syndrome and cardiac arrest in a COVID-19 patient
por: Tsimploulis, Apostolos, et al.
Publicado: (2020)

Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
por: Abdul-Rahim, Azmil H., et al.
Publicado: (2017)

Rhythm Control in Patients with Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
por: Prasitlumkum, Narut, et al.
Publicado: (2021)

The association of cardiac troponin and cardiovascular events in patients with concomitant heart failure preserved ejection fraction and atrial fibrillation
por: Kim, Bum Sung, et al.
Publicado: (2023)

Epicardial Adipose Tissue and Development of Atrial Fibrillation (AFIB) and Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Zain, Sarmad, et al.
Publicado: (2023)

Corrigendum to: Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
Publicado: (2018)

Left Atrial Ejection Force as a Marker for the Diagnosis of Heart Failure with Preserved Ejection Fraction
por: Hafez, Mohamed Saber, et al.
Publicado: (2021)

Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation
por: Borgognone, Alessandra, et al.
Publicado: (2018)

Plasmatic Levels of N-terminal Pro-BNP in Elderly Patients with Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction
por: ZĂGREANU, Vasile Mircea, et al.
Publicado: (2017)

Significant functional tricuspid regurgitation portends poor outcomes in patients with atrial fibrillation and preserved left ventricular ejection fraction
por: Prapan, Natthaporn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1asdhhotv6cqhb55rmn4q90mph